I thought some of you might be interested to know of the 14th International Thyroid Congress being held right now (from 11th to 16th September 2010) in Paris, at the Palais des Congrès.
The conference website is here:
From the Welcome Messages:
Dear colleagues, dear friends,
Every five years the American, European, Asia-Oceania and Latin-American thyroid associations combine their annual scientific meetings into one: the International Thyroid Congress. The congress is widely regarded as a major event in international thyroidology due to its truly global character. Here you have the chance to meet in person the authors of your favourite thyroid papers. And the congress provides a golden opportunity to get updated with the most recent developments in the field. Endocrinology is booming worldwide, and thyroidology is likewise doing very well. Real progress is being made in basic thyroidology, and it is amazing to see how much of this basic knowledge is already translated into clinical applications. The Programme Organising Committee has been keen to stress translational research in the scientific programme where possible. Of particular interest to clinicians will be the outcome of a number of randomized clinical trials, to be presented for the first time at the congress. We have also designed new ventures in the programme (see page 7), and it is hard to imagine you will not like it.
But the scientific programme outlined in this announcement constitutes just a part of the full programme. The missing part will be composed from submitted abstracts to be presented in 32 oral communications sessions, 4 poster viewing sessions and 24 poster discussion sessions. We therefore invite you to submit your best research to the congress! The surroundings of the meeting venue are well suited to discuss your research findings in a typical french manner over wine and food in one of the many bars and restaurants. After all, you can’t beat Paris! So I do hope to see you in Paris.
Wilmar M. Wiersinga
Chairman of the Programme Organising Committee
It seems likely that the usual flow of new papers will become a torrent during and shortly after the conference. How much of this information gets incorporated into clinical applications remains to be seen. But however cynical, it remains true that the sheer volume of information is staggering, and in time at least some of it surely will reach us?
All the best